Consumer attitudes and behaviors associated with direct-to-consumer prescription drug marketing

Journal of Consumer Marketing

Volumn 24, Issue 2, 2007, Pages 100-109

  Friedman, Michael ^a   Gould, James ^b  

^a PURDUE PHARMA L P   (United States)

^b PACE UNIVERSITY   (United States)

Author keywords

Advertising; Consumer behaviour; Direct marketing; Marketing strategy; Medical prescriptions; Pharmaceutical products

Indexed keywords

EID: 33947239637     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760710737102     Document Type: Article

References (39)

1. Advertising Age (2005), April.
2. Aikin, K.J., Swasy, J.L. and Braman, A.C. (2004), Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs - Summary of FDA Survey Research Results, Final Report, US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluations and Research, Washington, DC, November 19.
3. Allison-Ottey, S.D. (2003), "DTC and the African American physician and patient", paper presented at the US Food and Drug Administration Direct to Consumer Promotion Public Meeting, September 22-23.
4. Auton, F. (2004), "The advertising of pharmaceuticals direct-to-consumers: a critical review of the literature and debate", International Journal of Advertising, Vol. 23 No. 1, pp. 5-52.
5. Axelrod, A. and Moore, D. (2004), "Direct-to-consumer advertising: a classic case of cognitive dissonance", DTC Perspectives, December, p. 28.
6. DTC Perspective (2005), "Spending review", June, pp. 11-12.
7. Edwards, J. (2005), "FDA: quality of DTC ads is in noticeable decline: director of drug marketing lays down law to industry execs", Brandweek, Vol. 46 No. 18, May 2, p. 12.
8. FDA News (2005), "AMA to study pharmaceutical DTC advertising", July 8, available at: www.fdanews.com.
9. Foley, L.A. and Gross, D.J. (2000), Are Consumers Well Informed About Prescription Drugs?, No. 2000-04, AARP Public Policy Institute, Washington, DC, April.
10. Goetzl, I. and Teinowitz, D. (2002), "Drug ad pressure: DTC ads dodge bullet; no Thomas curbs; outlays may flatten", Advertising Age, Vol. 73, May 6, p. 59.
11. Golodner, L. (2003), "National Consumers League October 2002 survey", paper presented at the US Food and Drug Administration Direct to Consumer Promotion Public Meeting, September 22-23.
12. Hunt, M. (1998), "Direct to consumer advertising of prescription drugs - a background paper", National Health Forum, The George Washington University, Washington, DC, April.
13. Long, D.M. (2005), "US strategic management review 2005-2009", presentation, IMS Health Incorporated and Affiliates, Norwalk, CT.
14. McLinden, M., Sandino, J. and Willard, T. (2004), "Fast relief: the prescription generic Omeprazole DTC launch", DTC Perspectives, March, pp. 44-7.
15. Medical Marketing & Media (2002), "FDA moves to improve review and enforcement efforts", Vol. 37 No. 4, April, p. 8.
16. Medical Marketing & Media (2003), August.
17. Rosenthal, M.B., Berndt, E.R., Donohue, J.M., Frank, R.G. and Epstein, A.M. (2002), "Promotion of prescription drugs to consumers", New England Journal of Medicine, Vol. 346, February 14, pp. 498-505.
18. Slaughter, E. (2003), "Consumer reaction to DTC advertising of prescription medicines 1997-2002, prevention and men's health magazines", paper presented at the US Food and Drug Administration Direct to Consumer Promotion Public Meeting, September 22-23.
19. Teinowitrz, I. (2003), "DTC ads become an issue in race for democratic nomination", Advertising Age, Vol. 74 42, October 20, p. 8.
20. Vogt, D.U. (2005), Direct to Consumer Advertising of Prescription Drugs, CRS Report for Congress, Congressional Research Service, The Library of Congress, Washington, DC, March 25.
21. Weissman, J.S., Blumenthal, D., Silk, A.J., Leitman, R., Zapert, K., Newman, M. and Feibelman, S. (2003), "Consumer and physician reports on the health effects of DTCA", paper presented at the US Food and Drug Administration Direct to Consumer Promotion Public Meeting, MGH Institute for Health Policy & Harris Interactive, September 22-23.
22. Wilkes, M.S., Bell, R.A. and Kravitz, R. (2000), "Direct to consumer prescription drug advertising: trends, impact, and implications", Health Affairs, Vol. 19 No. 2, March/April, pp. 110-28.
23. Woloshin, S., Schwartz, L.M., Tremmel, J. and Welch, H.G. (2001), "Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?", The Lancet, Vol. 358 No. 9288, October 6, p. 1141.
24. American Medical Association (n.d.), "Physician data resources", available at: www.ama-assn.org/ama/pub/category/2670.html.
25. Bell, R.A., Kravitz, R. and Wilkes, M.S. (1999), "Direct to consumer prescription drug advertising and the public", Journal of General Internal Medicine, Vol. 14, November, pp. 651-7.
26. Berndt, E.R. (2005), "To inform or persuade? Direct-to-consumer advertising of prescription drugs", New England Journal of Medicine, Vol. 352, January 27, pp. 325-8.
27. Calfee, J.E. (2002), "Public policy issues in direct-to consumer advertising of prescription drugs", Journal of Public Policy and Marketing, September 23.
28. Donohue, J. (2003), "Pharmaceutical promotion in an age of consumerism", Doctor of Philosophy thesis, Harvard University, Cambridge, MA, October.
29. Donohue, J. and Berndt, E.R. (2004), "Effects of direct-to-consumer advertising on medication choice: the case of antidepressants", The Journal of Public Policy and Marketing, Vol. 23 No. 2, Fall, pp. 115-27.
30. Drug Store News (2003), Vol. 25 No. 6, April 28, p. 26.
31. (The) Henry J. Kaiser Foundation (2003), Impact of Direct to Consumer Advertising on Prescription Drug Spending, Henry J. Kaiser Foundation, Menlo Park, CA, June.
32. Kravitz, R.L., Epstein, R.M., Feldman, M.D., Franz, C.E., Azari, R., Wilkes, M.S., Hinton, L. and Franks, P. (2005), "Influence of patients' requests for direct-to-consumer advertised antidepressants", JAMA, Vol. 293 No. 16, April 27, pp. 1995-2002.
33. (The) Lancet (2005), "Reigning in direct to consumer advertising", Vol. 365 No. 9466, April, p. 1204.
34. Med Ad News (2005), "The new face of consumer advertising", June, pp. 1-11.
35. Mintzes, B., Barer, M.L., Kravitz, R.L., Bassett, K., Lexchin, J., Kazanjian, A., Evans, R.G., Pan, R. and Marion, S.A. (2003), "How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without DTCA", Canadian Medical Association Journal, September 2, pp. 169-73.
36. Palumbo, F.B. and Mullins, C.D. (2002), "The development of direct-to-consumer prescription drug advertising regulation", Food and Drug Law Journal, Vol. 57 No. 3, pp. 423-44.
37. PhRMA (n.d.), "Direct-to-consumer advertising strengthens our health care system", available at: www.phrma.org/issues/directconsumer (accessed July 12, 2005).
38. (The) Pink Sheet Daily (2005), "PhRMA board gives preliminary nod to voluntary DTC guidelines", Vol. 11, July 21.
39. United States General Accounting Office (2002), Prescription Drugs - FDA Oversight of Direct-to-Consumer Advertising Has Limitations, United States General Accounting Office, Washington, DC, October.